118 filings
ARS
2023 FY
QNCX
Quince Therapeutics Inc
24 Apr 24
Annual report to shareholders
4:10pm
DEFA14A
QNCX
Quince Therapeutics Inc
24 Apr 24
Additional proxy soliciting materials
4:05pm
DEF 14A
QNCX
Quince Therapeutics Inc
Definitive proxy
24 Apr 24
4:01pm
PRE 14A
QNCX
Quince Therapeutics Inc
Preliminary proxy
11 Apr 24
4:39pm
S-8
QNCX
Quince Therapeutics Inc
1 Apr 24
Registration of securities for employees
5:21pm
8-K
6jc eqhggaor5rp6v
15 Feb 24
Departure of Directors or Certain Officers
4:00pm
8-K
o86w8ir49j4abls0
29 Jan 24
Departure of Directors or Certain Officers
4:00pm
8-K/A
xvef3qp lywzpav4kg
5 Jan 24
Independent Auditors’ Report
4:01pm
8-K
1ot3nnjatdhvhzbq5vp
3 Jan 24
Other Events
4:02pm
8-K
2t287
22 Dec 23
Termination of a Material Definitive Agreement
4:08pm
8-K
ntgrg
8 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
8-K
y2f4 6ugcrv
26 Oct 23
Departure of Directors or Certain Officers
4:01pm
8-K
ryl5ou qpw5hej4ak4gt
23 Oct 23
Entry into a Material Definitive Agreement
4:05pm
8-K
fa19wrno3sij0nu
6 Sep 23
Entry into a Material Definitive Agreement
7:18am
8-K
jrahpqy2mb6xbc
10 Aug 23
Departure of Directors or Certain Officers
5:05pm
8-K
ik81r7r0q8k
24 Jul 23
Entry into a Material Definitive Agreement
7:16am
8-K
ozd71ftqoxzdackwdk
25 May 23
Submission of Matters to a Vote of Security Holders
4:23pm